Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market
Background: Cardiovascular disease is both highly prevalent and expensive to treat. Many novel anticoagulants, fibrinolytics, and antiplatelet agents have been found to be effective in decreasing the morbidity and mortality associated with cardiovascular disease. In the Indian market, there is large...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Eldaghayes Publisher
2019-05-01
|
| Edice: | National Journal of Physiology, Pharmacy and Pharmacology |
| Témata: | |
| On-line přístup: | http://www.ejmanager.com/fulltextpdf.php?mno=32277 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|